IP Library Granted Patent US 7,877,147
Granted Patent B2
US 7,877,147 · App. 11/656,808 · Granted Jan 25, 2011

Stimulation of the sphenopalatine ganglion for treating depression

Assignee: Brainsgate Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,877,147
App. No.
11/656,808
Granted
Jan 25, 2011
Kind
B2
Abstract

Apparatus for modifying a property of a brain of a patient is provided, including one or more electrodes ( 7 ), adapted to be applied to a site selected from a group of sites consisting of: a sphenopalatine ganglion (SPG) ( 6 ) of the patient and a neural tract originating in or leading to the SPG. A control unit ( 8 ) is adapted to drive the one or more electrodes to apply a current to the site capable of inducing (a) an increase in permeability of a blood-brain barrier (BBB) of the patient, (b) a change in cerebral blood flow of the patient, and/or (c) an inhibition of parasympathetic activity of the SPG.

Claims (12)

1. A method comprising:

identifying that a patient suffers from depression; and

treating the depression by directly applying a current to a sphenopalatine ganglion (SPG) of the patient, and configuring the current to activate the site to induce a change in cerebral blood flow (CBF) of the patient.

2. A method according to claim 1 , wherein applying the current comprises implanting an electrode in contact with or in a vicinity of the SPG, designated to remain in the patient for a period greater than about one month.

3. A method according to claim 1 , wherein applying the current comprises placing an electrode in contact with or in a vicinity of the SPG implanting an implanted unit, and communicating with the implanted unit by wireless communication from a position external to the patient.

4. A method according to claim 1 , wherein applying the current comprises implanting a stimulator through a nasal cavity of the patient.

5. A method according to claim 1 , wherein configuring the current comprises configuring the current to induce an increase in the CBF.

6. A method according to claim 1 , wherein configuring the current comprises configuring the current to induce vasodilation of middle cerebral and anterior cerebral lumens of the patient.

7. A method according to claim 1 , wherein treating the depression comprises treating the depression on a long-term basis.

8. A method comprising:

identifying that a patient suffers from anxiety; and

treating the anxiety by directly applying a current to a sphenopalatine ganglion (SPG) of the patient, and configuring the current to activate the site to induce a change in cerebral blood flow (CBF) of the patient.

Continuity (4)
Continuation 1150279000 · Aug 11, 2006
Continuation 1025871400
Provisional Application 6020317200 · May 8, 2000
Related Publication 20070142875A1 · Jun 21, 2007